Improving vaccine acceptance in prisons through community engagement
Addressing Vaccine AcceptaNce in Carceral Settings through Community Engagement (ADVANCE)
['FUNDING_R01'] · YALE UNIVERSITY · NIH-10911941
This study is all about finding better ways to encourage people in prisons and the staff who work there to get vaccinated against COVID-19, so everyone can stay healthier and safer together.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | YALE UNIVERSITY (nih funded) |
| Locations | 1 site (NEW HAVEN, UNITED STATES) |
| Trial ID | NIH-10911941 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing vaccine acceptance among incarcerated individuals and correctional staff, who have been disproportionately affected by COVID-19. By addressing the unique social norms and distrust within correctional settings, the project aims to develop effective strategies to increase vaccination rates. The approach involves community engagement and adapting successful interventions from other populations to fit the correctional environment. The goal is to mitigate the spread of COVID-19 in prisons and the surrounding communities.
Who could benefit from this research
Good fit: Ideal candidates for this research include incarcerated individuals and correctional staff, particularly those from Black and Latinx communities who are disproportionately affected by COVID-19.
Not a fit: Patients who are not involved in the correctional system or who do not have access to prison healthcare services may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to higher vaccination rates in prisons, ultimately reducing COVID-19 transmission and improving public health outcomes.
How similar studies have performed: Previous research has shown success in improving vaccine acceptance in community settings, but this approach specifically tailored for correctional environments is novel.
Where this research is happening
NEW HAVEN, UNITED STATES
- YALE UNIVERSITY — NEW HAVEN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PUGLISI, LISA BALZANO — YALE UNIVERSITY
- Study coordinator: PUGLISI, LISA BALZANO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.